
|Podcasts|January 18, 2022
SUS – an Acronym for “Single Use Systems” or “Supply Under Shortage”?
Author(s)Single Use Support
It is the bottleneck in pharmaceutical manufacturing: Lead times. Which are the approaches that may secure business continuity? What are ways to overcome dependencies on vendors’ supply? Barbara Fischer gives insights on how single-use system providers tackle this industry-wide challenge in supply chain.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
FDA October 2025 Draft Guidance Sparks Industry Biosimilars Buzz
2
How Biopharma Navigates the 2026 Economic Shift
3
Adenovirus Vectors, Cyclodextrins and the Patient Experience: A Deep Dive
4
EC’s High-Dose Aflibercept Approval Highlights Durable Anti-VEGF Retinal Therapy
5




